SEPHS1 promotes SMAD2/3/4 expression and hepatocellular carcinoma cells invasion.
Shu YangHongying ZhangHua YangJin ZhangJiao WangTing LuoYangfu JiangHui HuaPublished in: Experimental hematology & oncology (2021)
SEPHS1 is a positive regulator of TGF-β/SMAD signaling that is up-regulated in HCC. Increased SEPHS1 expression may indicate poor prognosis for patients with HCC.